| Particulars |
|
|
|
|
Company Name
| Ipca Laboratories Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
25.37 |
B.V. (₹) |
314.50 |
| Sales(₹ Cr.) |
7,336.75 |
NP (₹ Cr.) |
1,135.98 |
| NP Var% |
38.00 |
Div% |
600.00 |
| CPS(₹) |
55.40 |
EPS (₹) |
44.80 |
| Traded Value(₹ Lakhs) |
41.42 |
52 Week High |
1,941.00 |
| 52 Week Low |
1,253.00 |
Price BSE |
1,763.00 |
| Price NSE |
1,763.00 |
Market Capital (₹ Cr.) |
44,720.44 |
| P/C Ratio |
31.80 |
P/E Ratio |
39.40 |
| Price Vs.BV |
5.61 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1,814.35 |
| NP(₹ Cr.) |
284.53 |
NP Var % |
112.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
6,394.25 |
| OPM |
-0.94 |
NP |
697.62 |
| NP Var% |
38.48 |
EPS |
44.78 |
| PE |
39.36 |
|
|